{"organizations": [], "uuid": "4c22600a712c21ec37aec553b1a4dca2dd96736e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-glaukos-submits-ide-application-to/brief-glaukos-submits-ide-application-to-fda-to-study-istent-infinite-trabecular-micro-bypass-system-idUSASB0BZJD", "country": "US", "domain_rank": 408, "title": "BRIEF-Glaukos Submits IDE Application To FDA To Study iStent Infinite Trabecular Micro-Bypass System", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T14:12:00.000+02:00", "replies_count": 0, "uuid": "4c22600a712c21ec37aec553b1a4dca2dd96736e"}, "author": "", "url": "https://www.reuters.com/article/brief-glaukos-submits-ide-application-to/brief-glaukos-submits-ide-application-to-fda-to-study-istent-infinite-trabecular-micro-bypass-system-idUSASB0BZJD", "ord_in_thread": 0, "title": "BRIEF-Glaukos Submits IDE Application To FDA To Study iStent Infinite Trabecular Micro-Bypass System", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "glaukos corp", "sentiment": "none"}, {"name": "glaukos corp", "sentiment": "none"}, {"name": "trabecular micro-bypass system reuters staff  jan", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 12 PM / Updated 12 minutes ago BRIEF-Glaukos Submits IDE Application To FDA To Study iStent Infinite Trabecular Micro-Bypass System Reuters Staff \nJan 3 (Reuters) - Glaukos Corp: \n* GLAUKOS SUBMITS IDE APPLICATION TO FDA TO STUDY ISTENT INFINITE™ TRABECULAR MICRO-BYPASS SYSTEM \n* GLAUKOS CORP - ‍SUBMITTED IDE APPLICATION TO FDA SEEKING AUTHORIZATION TO STUDY ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-03T14:12:00.000+02:00", "crawled": "2018-01-03T14:29:15.042+02:00", "highlightTitle": ""}